In situ cell cycle analysis in giant cell tumor of bone reveals patients with elevated risk of reduced progression-free survival

Objective - Giant cell tumor of bone (GCTB) is a frequently recurring locally aggressive osteolytic lesion, where pathological osteoclastogenesis and bone destruction are driven by neoplastic stromal cells. Here, we studied if cell cycle fractions within the mononuclear cell compartment of GCTB can...

Full description

Saved in:
Bibliographic Details
Main Authors: Maros, Máté E. (Author) , Schnaidt, Sven (Author) , Balla, Péter (Author) , Kelemen, Zoltán (Author) , Sapi, Zoltan (Author) , Szendroi, Miklos (Author) , Laszlo, Tamas (Author) , Forsyth, Ramses (Author) , Picci, Piero (Author) , Krenacs, Tibor (Author)
Format: Article (Journal)
Language:English
Published: 22 June 2019
In: Bone
Year: 2019, Volume: 127, Pages: 188-198
ISSN:1873-2763
DOI:10.1016/j.bone.2019.06.022
Online Access:Verlag, Volltext: https://doi.org/10.1016/j.bone.2019.06.022
Verlag: http://www.sciencedirect.com/science/article/pii/S8756328219302546
Get full text
Author Notes:Mate E. Maros, Sven Schnaidt, Peter Balla, Zoltan Kelemen, Zoltan Sapi, Miklos Szendroi, Tamas Laszlo, Ramses Forsyth, Piero Picci, Tibor Krenacs

MARC

LEADER 00000caa a2200000 c 4500
001 1681806495
003 DE-627
005 20220817024016.0
007 cr uuu---uuuuu
008 191113s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.bone.2019.06.022  |2 doi 
035 |a (DE-627)1681806495 
035 |a (DE-599)KXP1681806495 
035 |a (OCoLC)1341250674 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Maros, Máté E.  |d 1986-  |e VerfasserIn  |0 (DE-588)1144379407  |0 (DE-627)1004715153  |0 (DE-576)495364827  |4 aut 
245 1 0 |a In situ cell cycle analysis in giant cell tumor of bone reveals patients with elevated risk of reduced progression-free survival  |c Mate E. Maros, Sven Schnaidt, Peter Balla, Zoltan Kelemen, Zoltan Sapi, Miklos Szendroi, Tamas Laszlo, Ramses Forsyth, Piero Picci, Tibor Krenacs 
264 1 |c 22 June 2019 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.11.2019 
520 |a Objective - Giant cell tumor of bone (GCTB) is a frequently recurring locally aggressive osteolytic lesion, where pathological osteoclastogenesis and bone destruction are driven by neoplastic stromal cells. Here, we studied if cell cycle fractions within the mononuclear cell compartment of GCTB can predict its progression-free survival (PFS). - Methods - 154 cases (100 primaries and 54 recurrent) from 139 patients of 40 progression events, was studied using tissue microarrays. Ploidy and in situ cell cycle progression related proteins including Ki67 and those linked with replication licensing (mcm2), G1-phase (cyclin D1, Cdk4), and S-G2-M-phase (cyclin A; Cdk2) fractions; cell cycle control (p21waf1) and repression (geminin), were tested. The Prentice-Williams-Peterson (PWP) gap-time models with the Akaike information criterion (AIC) were used for PFS analysis. - Results - Cluster analysis showed good correlation between functionally related marker positive cell fractions indicating no major cell cycle arrested cell populations in GCTB. Increasing hazard of progression was statistically associated with the elevated post-G1/S-phase cell fractions. Univariate analysis revealed significant negative association of poly-/aneuploidy (p<0.0001), and elevated cyclin A (p<0.001), geminin (p=0.015), mcm2 (p=0.016), cyclin D1 (p=0.022) and Ki67 (B56: p=0.0543; and Mib1: p=0.0564 -strong trend) positive cell fractions with PFS. The highest-ranked multivariate interaction model (AIC=269.5) also included ploidy (HR 5.68, 95%CI: 2.62-12.31, p<0.0001), mcm2 (p=0.609), cyclin D1 (HR 1.89, 95%CI: 0.88-4.09, p=0.105) and cyclin A (p<0.0001). The first and second best prognostic models without interaction (AIC=271.6) and the sensitivity analysis (AIC=265.7) further confirmed the prognostic relevance of combining these markers. - Conclusion - Ploidy and elevated replication licensing (mcm2), G1-phase (cyclin D1) and post-G1 phase (cyclin A) marker positive cell fractions, indicating enhanced cell cycle progression, can assist in identifying GCTB patients with increased risk for a reduced PFS. 
650 4 |a Cyclin A 
650 4 |a Cyclin D1 
650 4 |a Giant cell tumor of bone 
650 4 |a mcm2 
650 4 |a Mononuclear cell cycle fractions 
650 4 |a Neoplastic stromal cells 
650 4 |a ploidy 
650 4 |a Tumor progression 
700 1 |a Schnaidt, Sven  |e VerfasserIn  |0 (DE-588)1122755198  |0 (DE-627)876133685  |0 (DE-576)322299527  |4 aut 
700 1 |a Balla, Péter  |d 1981-  |e VerfasserIn  |0 (DE-588)1147517843  |0 (DE-627)100624638X  |0 (DE-576)495848530  |4 aut 
700 1 |a Kelemen, Zoltán  |d 1969-  |e VerfasserIn  |0 (DE-588)136240291  |0 (DE-627)578121123  |0 (DE-576)300915152  |4 aut 
700 1 |a Sapi, Zoltan  |e VerfasserIn  |4 aut 
700 1 |a Szendroi, Miklos  |e VerfasserIn  |4 aut 
700 1 |a Laszlo, Tamas  |e VerfasserIn  |4 aut 
700 1 |a Forsyth, Ramses  |e VerfasserIn  |4 aut 
700 1 |a Picci, Piero  |e VerfasserIn  |4 aut 
700 1 |a Krenacs, Tibor  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Bone  |d Amsterdam [u.a.] : Elsevier Science, 1985  |g 127(2019), Seite 188-198  |h Online-Ressource  |w (DE-627)306320177  |w (DE-600)1496324-3  |w (DE-576)081952945  |x 1873-2763  |7 nnas  |a In situ cell cycle analysis in giant cell tumor of bone reveals patients with elevated risk of reduced progression-free survival 
773 1 8 |g volume:127  |g year:2019  |g pages:188-198  |g extent:11  |a In situ cell cycle analysis in giant cell tumor of bone reveals patients with elevated risk of reduced progression-free survival 
856 4 0 |u https://doi.org/10.1016/j.bone.2019.06.022  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S8756328219302546  |x Verlag 
951 |a AR 
992 |a 20191113 
993 |a Article 
994 |a 2019 
998 |g 1122755198  |a Schnaidt, Sven  |m 1122755198:Schnaidt, Sven  |p 2 
998 |g 1144379407  |a Maros, Máté E.  |m 1144379407:Maros, Máté E.  |d 60000  |d 63000  |e 60000PM1144379407  |e 63000PM1144379407  |k 0/60000/  |k 1/60000/63000/  |p 1  |x j 
999 |a KXP-PPN1681806495  |e 3539687807 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 13.11.2019"],"relHost":[{"language":["eng"],"pubHistory":["Nachgewiesen 6.1985 -"],"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"display":"International Bone and Mineral Society","role":"isb"}],"note":["Gesehen am 22.01.2020","Ungezählte Beil.: Supplement"],"title":[{"title_sort":"Bone","subtitle":"cell molecular biology, pathophysiology, treatment ; official journal of the International Bone and Mineral Society","title":"Bone"}],"disp":"In situ cell cycle analysis in giant cell tumor of bone reveals patients with elevated risk of reduced progression-free survivalBone","recId":"306320177","part":{"year":"2019","volume":"127","pages":"188-198","text":"127(2019), Seite 188-198","extent":"11"},"id":{"zdb":["1496324-3"],"issn":["1873-2763"],"eki":["306320177"]},"origin":[{"dateIssuedDisp":"1985-","publisher":"Elsevier Science","dateIssuedKey":"1985","publisherPlace":"Amsterdam [u.a.]"}]}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"11 S."}],"language":["eng"],"title":[{"title":"In situ cell cycle analysis in giant cell tumor of bone reveals patients with elevated risk of reduced progression-free survival","title_sort":"In situ cell cycle analysis in giant cell tumor of bone reveals patients with elevated risk of reduced progression-free survival"}],"person":[{"display":"Maros, Máté E.","role":"aut","given":"Máté E.","family":"Maros"},{"display":"Schnaidt, Sven","given":"Sven","role":"aut","family":"Schnaidt"},{"display":"Balla, Péter","family":"Balla","given":"Péter","role":"aut"},{"display":"Kelemen, Zoltán","role":"aut","given":"Zoltán","family":"Kelemen"},{"display":"Sapi, Zoltan","given":"Zoltan","role":"aut","family":"Sapi"},{"family":"Szendroi","given":"Miklos","role":"aut","display":"Szendroi, Miklos"},{"display":"Laszlo, Tamas","given":"Tamas","role":"aut","family":"Laszlo"},{"display":"Forsyth, Ramses","family":"Forsyth","role":"aut","given":"Ramses"},{"display":"Picci, Piero","family":"Picci","role":"aut","given":"Piero"},{"given":"Tibor","role":"aut","family":"Krenacs","display":"Krenacs, Tibor"}],"recId":"1681806495","name":{"displayForm":["Mate E. Maros, Sven Schnaidt, Peter Balla, Zoltan Kelemen, Zoltan Sapi, Miklos Szendroi, Tamas Laszlo, Ramses Forsyth, Piero Picci, Tibor Krenacs"]},"origin":[{"dateIssuedDisp":"22 June 2019","dateIssuedKey":"2019"}],"id":{"doi":["10.1016/j.bone.2019.06.022"],"eki":["1681806495"]}} 
SRT |a MAROSMATEEINSITUCELL2220